EXTRACTA Moléculas Naturais S.A. is a Brazilian R&D service provider to BioPharma, Veterinary, Cosmetics and Agro industries, offering state-of-the-art HTS screening against client targets and isolation of New Chemical Entities from Brazilian biodiversity.
EXTRACTA´s own BANK OF CHEMICAL BIODIVERSITY® is the largest, constantly growing collection of ready-to-screen compounds derived from Brazilian biodiversity within the legal framework of the 1992 Convention on Biological Diversity.
A growing library of plant extracts and their fractions totaling nearly 40,000 samples readyfor screening against bioassays in a 96-well plate format. The library contains nearly5,000 plant species professionally collected in the Atlantic Rain Forest and Oriental Amazon.This highly diversified material generated close to 11,000 different crude extracts obtainedfrom plant parts and close to 29,000 fractions that together constitute the basis for everyscreening exercise
EXTRACTA offers partners uncomplicated access to this immense chemical reservoir with comprehensive, worldwide IP arrangements (no IP stacking).
Current Collaborations: GlaxoSmithKline, Genzyme Corporation and Natura (largest cosmetic/phytoremedies concern in Brazil.
EXTRACTA Moléculas Naturais S.A.
Av. 24 s/n Quadra A Lote 6 e 7 - Cidade Universitária
Rio de Janeiro
Phone (+5521) 3867-5608
Site: http://www.extracta.com.br
Saturday, December 02, 2006
